PMDA drug package insert
ポリスチレンスルホン酸Ca散96.7％分包5.17g〈ハチ〉
PMDA Prescription drug · 東洋製薬化成株式会社 · package insert Jun 24, 2025
Key facts
| Brand names | ポリスチレンスルホン酸Ca散96.7％分包5.17g〈ハチ〉 |
|---|---|
| Nonproprietary names | ポリスチレンスルホン酸カルシウム |
| Companies | 製造販売／東洋製薬化成株式会社, 販売／小野薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 高カリウム血症改善剤 |
| Therapeutic category codes | 87219 |
| YJ codes | 2190016B1043 |
| Approval numbers | 30200AMX00474 |
| Package insert edition | 第2版 |
| Package insert date | Jun 24, 2025 |
| PMDA document key | 480199_2190016B1043_1 |
| PMDA company code | 480199 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: